Pregnancy

Pregnancy begins with the fertilization of the ovum and its subsequent implantation into the uterine wall. The duration of pregnancy is counted in weeks of gestation from the first day of the last menstrual period and on average lasts 40 weeks. Presumptive signs of pregnancy include amenorrhea, nausea and vomiting, and breast enlargement and tenderness. Preconception counseling assists in the planning of pregnancy through education and risk assessment to help ensure best possible outcomes. Pregnancy can be confirmed definitively via positive serum or urine hCG tests and detection of the embryo on ultrasound. Ultrasound is also used to determine the gestational age and date of delivery. Women experience several physiological changes during pregnancy (e.g., increased plasma volume, venous stasis, increased insulin secretion, increased oxygen demand), which can lead to symptoms and conditions that may require treatment (e.g., peripheral edema, insulin resistance, hypercoagulability, dyspnea). Regular check-ups should be performed to detect potential high-risk pregnancies as well as fetal and maternal complications.

See also “Prenatal care” and “Maternal complications during pregnancy.”

Gravidity, parity, and duration of pregnancy ^[1]

• Gravidity: the number of times a woman has been pregnant, regardless of pregnancy outcome
  • Nulligravidity: no history of pregnancy
  • Primigravidity: history of one pregnancy
  • Multigravidity: history of two or more pregnancies
• Parity: the number of pregnancies that reached beyond 20 weeks' gestation or terminated with the birth of an infant weighing > 500 g
  • Nulliparity: absence of pregnancies that reached beyond 20 weeks' gestation or birth of an infant weighing > 500 g
  • Primiparity: a history of one pregnancy that reached beyond 20 weeks' gestation or birth of an infant weighing > 500 g
  • Multiparity: a history of more than one pregnancy that reached beyond 20 weeks' gestation or birth of an infant weighing > 500 g
• Fetal age ^[2]
  • Counted as completed weeks of gestation and completed days (0–6) of the current week of pregnancy
  • Gestational age: estimated fetal age (in weeks and days) calculated from the first day of the last menstrual period
  • Conceptional age: the age (in weeks and days) of the fetus calculated from the day of conception (fertilization)
• Duration of pregnancy
  • Normal duration of pregnancy: 40 weeks (280 days)
  • Periviable birth: live birth occurring between 20–25 weeks of pregnancy
  • Preterm birth: live birth before the completion of 37 weeks (< 37 0/7) of pregnancy
  • Postterm birth: live birth after 42 weeks (> 42 0/7) of pregnancy
• Trimesters of pregnancy
  • First trimester (weeks 1–13)
  • Second trimester (weeks 14–26)
  • Third trimester (weeks 27–40)

Recording systems

Trimesters of pregnancy

• First trimester (week 1–13)
• Second trimester (week 14–26)
• Third trimester (week 27–40)

Stages of pregnancy

The earlier disruptions take place during fetal development, the more complicated the resulting congenital anomalies!

References:^[3][4]

General principles

• Fertile women of reproductive age should be asked about their intention to become pregnant by their healthcare provider (all those planning to become pregnant should receive counseling).
• Preconception counseling aims to:
  • Identify and address any modifiable factors that may negatively affect pregnancy and childbirth.
  • Educate women and men about options for risk reduction and elimination.

Patient medical history

• Medical conditions: review history and identify chronic medical conditions that may affect pregnancy (e.g., hypothyroidism, diabetes mellitus, chronic hypertension)
  • Hypothyroidism
    • Screen women with a desire to conceive with risk factors for thyroid disease (e.g., age > 30 years, obesity, history of head or neck radiation). ^[5]
    • Treat women with a desire to conceive with elevated TSH with L-thyroxine until TSH levels are normal.
  • Diabetes mellitus
    • Educate affected women about the importance of maintaining normal glycemic levels before and during pregnancy.
    • Assess for complications of diabetes (e.g., retinopathy, nephropathy).
    • Aim for an HbA1c < 6.5%. ^[6]
  • Hypertension
    • Assess for retinopathy, renal disease, and ventricular hypertrophy.
    • Avoid using ACE inhibitors and angiotensin receptor blockers, as they are teratogenic.
• Family history of inherited conditions: assess family history of genetic conditions and cancer (e.g., breast cancer, endometrial cancer, colon cancer) and refer couples with a positive history for counseling.
• Communicable diseases
  • HIV-infection
    • Screen all women for HIV.
    • Initiate antiretroviral therapy in all women with HIV.
    • Counsel women with HIV regarding the risk of vertical transmission.
  • Other infections: STIs, tuberculosis (screen women at high risk and manage as appropriate)
• Medications
  • Review current medications, including alternative medicine preparations (e.g., herbal medicine, naturopathy) and nutritional supplements.
  • Discontinue teratogenic drugs and switch to safer medications, if possible.
  • Adjust the regimen of necessary medications and consider using the lowest dose possible for potentially harmful agents.
• Immunizations
  • Measles, mumps, rubella (MMR vaccine), and varicella vaccine
    • Screen all women for immunity with antibody titers.
    • Nonimmune women should receive vaccination.
    • Counsel to avoid conceiving for 28 days after the last vaccine dose.
  • Influenza: Women who wish to conceive should receive the annual influenza vaccine.
  • Tetanus, diphtheria, and pertussis (Tdap vaccine): Women who wish to conceive should receive the Tdap vaccine according to the guidelines.
  • Hepatitis B vaccine: Vaccinate women with high risk for hepatitis B.
• Mental disorders
  • Review history of psychiatric disorders.
  • Inform about the risks of medication during pregnancy.
  • Screen women with no history of mental health conditions for anxiety and depression.

Lifestyle modifications

• Recommend maintaining a normal body weight prior to conception.
• Encourage regular moderate-intensity exercise.
• Nutrition
  • Screen for sufficient intake of macronutrients and micronutrients (calcium, iron, vitamin B12, vitamin B, vitamin D).
  • Ensure vitamin A is not taken in excess
  • Recommend intake of 0.4 mg of folic acid daily, ideally 4 weeks prior to conception, and continue for at least the first 2–3 months of pregnancy.
• Substance use
  • Screen all women for alcohol, tobacco, and recreational drug use.
  • Educate about associated adverse effects of substance use on maternal and fetal pregnancy outcomes.
  • Provide assistance and/or refer to the proper specialists for tobacco, alcohol, and recreational drug use cessation.

Management of exposures ^[7][8]

• Exposure to harmful agents
  • Advise patients to assess workplace and household for potentially harmful agents (e.g., heavy metals, solvents, chemicals).
  • Educate the patient about the avoidance of harmful agents and refer them to occupational medicine programs as needed.
• Exposure to violence
  • Screen for family violence at each visit.
  • If ongoing abuse is identified, providers should:
    • Provide community resources to the patient
    • Report the case as appropriate

• Presumptive signs
  • Amenorrhea
  • Nausea and vomiting
  • Breast enlargement and tenderness
  • Linea nigra: darkening of the midline skin of the abdomen
  • Hyperpigmentation of the areola
  • Abdominal bloating and constipation
  • Increased weight gain
  • Cravings for or aversions to certain foods
  • Increased urinary frequency
  • Fatigue

Human chorionic gonadotropin (hCG)

• Site of production: placental syncytiotrophoblast
• Structure
  • α-subunit: common to hCG, FSH, LH, and TSH
  • β-subunit: specific to the placenta (pregnancy tests measure the β-hCG levels)
• Function
  • Maintenance of the corpus luteum during the first 10 weeks of pregnancy (LH has a similar function)
  • Levels decrease after corpus luteum involution (placenta starts synthesizing its own estriol and progesterone)
• Pregnancy test: measurement of human chorionic gonadotropin (β-hCG)
  • Urine β-hCG test (e.g., home pregnancy test)
    • Qualitative test (less sensitive than serum pregnancy test)
    • β-hCG can be detected in urine 14 days after fertilization
  • Serum β-hCG test
    • Quantitative test (high sensitivity)
    • Detectable 6–9 days (on average) after fertilization

Ultrasound findings in normal pregnancy (abdominal or transvaginal)

• Confirms pregnancy
• At 5–6 weeks of pregnancy: detection of the embryo and cardiac activity
• At 10–12 weeks of pregnancy: detection of fetal heartbeat with doppler ultrasound
• At 18–20 weeks of pregnancy: fetal movements

Gestational age and estimated date of delivery

• Naegele rule: used to calculate the date of delivery (due date)
  • First day of the last menstrual period + 7 days + 1 year - 3 months
  • Inaccurate if:
    • The date of the last menstrual period is uncertain or unknown
    • The patient has irregular menstruation cycles
    • The patient conceived while taking contraceptive pills
• Ultrasonography
  • More accurate than Naegele rule
  • Measurement of the crown-rump length (CRL) in the first trimester
  • Measurement of biparietal diameter , fetal femoral length, and abdominal circumference in the second and third trimesters (can be used for determining gestational age starting at 13 weeks) ^[13]
• Symphysis fundal height: the length from the top of the uterus to the top of the pubic symphysis
  • Used to assess fetal growth and development from approx. 20 weeks' gestation onwards
  • Development is approx. 1 cm/week after 20 weeks
  • Correlates with gestational age

Cardiovascular system ^[14][15]

• ↑ Progesterone → ↓ vascular tone → ↓ peripheral vascular resistance (↓ afterload)
  • ↑ Cardiac output by up to 40% (↑ preload)
  • ↑ Stroke volume (by 10–30%)
  • ↑ Heart rate (by ∼ 12–18 bpm) → ↑ uterine perfusion
  • ↓ Mean arterial pressure
• Innocent systolic murmur
• The apex beat is displaced upward.
• Varicosity and edema of lower limbs
• Aggravation of preexisting valvular diseases

Respiratory system ^[15][16]

• ↑ Oxygen consumption (by approx. 20%)
• ↑ Intraabdominal pressure through uterine growth → dyspnea (the diaphragm is displaced upwards → ↓ total lung capacity, residual volume, functional residual capacity, and expiratory reserve volume)
• Progesterone stimulates the respiratory centers in the brain → hyperventilation (to eliminate fetal CO₂ more efficiently) → physiological, chronic compensated respiratory alkalosis
  • ↑ Tidal volume (by ∼ 40%) → ↑ minute ventilation
  • ↓ PCO₂ (∼ 30 mm Hg)

Renal system ^[15]

• ↑ GFR → ↓ BUN and creatinine
• ↑ Aldosterone → ↑ plasma volume and hypernatremia
• ↑ Glucose levels in urine (increased glomerular filtration results in overload of the glucose carrier responsible for its resorption)
• ↑ Urinary frequency

Endocrine system ^[15][17][18]

• Human placental lactogen: a hormone synthesized by syncytiotrophoblasts of the placenta, which promotes the production of insulin-like growth factors.
  • Increases insulin levels and causes insulin resistance
  • Maternal insulin resistance begins in the second trimester and peaks in the third trimester.
• Thyroid hormones
  • ↑ hCG → ↓ TSH levels during the first part of the first trimester
  • ↑ TBG → ↑ T₄ and T₃ → slightly increased free T₄ and T₃ levels during first trimester
  • Free T4 and T3 levels decrease during the second and third trimesters
• ↑ Triglycerides and cholesterol (due to increased lipolysis and fat utilization)
• Hyperplasia of lactotroph cells in the anterior pituitary; → physiological enlargement of the pituitary gland (up to 40% increase from pregestational volume)

Hematologic system ^[15][19][20]

• ↑ Plasma volume → ↓ hematocrit, especially towards the end of pregnancy (30–34^th week of gestation) → dilutional anemia (hemoglobin value rarely drops below 11 g/dL)
• ↑ RBC count (increases from 8–10^th week of gestation until the end of pregnancy)
• ↓ Platelet count ^[21]
• ↑ WBC count
• ↓ Albumin
• Hypercoagulability is due to an increase in fibrinogen, factor VII, and factor VIII and a decrease in protein S (reduces the risk of intrapartum blood loss).
• ↑ Alkaline phosphatase (placental isoenzyme)

Gastrointestinal system ^[15]

• ↑ Salivation
• Gastroesophageal reflux
• ↓ Motility → constipation
• Hemorrhoids

Musculoskeletal system ^[15]

• Increased pressure from the uterus, lumbar lordosis, and relaxation of the ligaments supporting the joints of the pelvic girdle can cause lower back pain.

Skin

• Spider angioma
• Palmar erythema
• Striae gravidarum: scarring that manifests as erythematous, violaceous, and/or hypopigmented linear striations on the abdomen.
• Hyperpigmentation: chloasma, linea nigra, hyperpigmentation of the nipples

Reproductive system

• Uterus: increase in size
• Vulva and vagina
  • Vaginal discharge
  • Formation of varicose veins
• Mammary glands increase in size

Physiological hypercoagulability during pregnancy leads to an increased risk of thrombosis. Patients with thrombophilia should receive adequate thrombosis prophylaxis.

A physiological systolic murmur may be heard due to increased cardiac output and increased plasma volume.

Basic principles

• Nutritional intake: must be adapted to meet the demands of both the mother and the fetus
• Dietary recommendations
  • Limit caffeine intake: daily recommended dose < 200 mg (this equals about 1–2 cups of coffee or 2–4 cups of caffeinated tea)
  • Avoid alcohol and tobacco use throughout pregnancy. ^[22]
  • Avoid unwashed or uncooked foods.
    • Fish (contamination with parasites and bacteria)
    • Milk products: high risk of congenital listeriosis
    • Meat: high risk of congenital toxoplasmosis
  • Avoid fish with possibly high levels of methylmercury, esp. tilefish, swordfish, shark, mackerel, and tuna.

Recommended weight-gain during pregnancy ^[33]

• Recommended weight-gain is determined by BMI prior to pregnancy
  • BMI < 18.5 (underweight): 28–40 lb (12–18 kg)
  • BMI 18.5–24.9 (normal weight): 25–35 lb (11–16 kg)
  • BMI 25–29.9 (overweight): 15–25 lb (7–11 kg)
  • BMI ≥ 30 (obese): 11–20 lb (5–9 kg)
• Average recommended daily calorie intake
  • First trimester: 2,200 kcal
  • Second and third trimester: 2,500 kcal
• Regular physical activity is recommended (see below).

• Regular physical activity (e.g., aerobic and strength-training exercise) is considered beneficial and is recommended before, during, and after pregnancy.
  • Careful evaluation of medical and obstetric disorders is necessary before recommending regular physical activity.
  • Exercise routines that are considered unsafe during pregnancy should be avoided or modified accordingly.

Physical activity should be discontinued in the event of the following: antepartum or postpartum hemorrhage, uterine contractions, amniotic fluid leakage, chest pain, dyspnea before exertion, dizziness, headaches, calf pain/swelling, and/or muscle weakness with impaired balance.

Early identification of high-risk pregnancies is vital in order to prevent the occurrence of maternal and fetal complications. They require regular prenatal care to monitor and support the pregnant mother (see “Prenatal care”).

Risk factors for a complicated pregnancy ^[35][36]

• Family history (medical and obstetric) of complicated pregnancies
• Personal history
  • Advanced maternal age (> 35 years)
  • First pregnancy
  • Multiple pregnancies
  • Multiparity (> 5 births)
  • Medical conditions (e.g., antiphospholipid syndrome, hypertension, diabetes mellitus, epilepsy, malignancies)
  • Social and environmental factors (e.g., drug use, stress)
  • Preexisting gynecological conditions (e.g., uterine leiomyoma, history of uterine surgery)
  • Prior complicated pregnancies
    • Premature delivery (< 38 weeks), baby with low birth weight, or a baby born with congenital defects
    • Prior cesarean delivery
    • Rhesus incompatibility
    • History of > 2 abortions or placental abruption
    • Use of assisted reproductive technologies: in vitro fertilization, ICSI
  • Complications that arise during pregnancy: See “Maternal complications during pregnancy” and section below.

Oligohydramnios ^[37]

• Definition: amount of amniotic fluid is less than expected for gestational age
• Etiology
  • Fetal anomalies
    • Urethral obstruction (e.g., posterior urethral valves)
    • Bilateral renal agenesis
    • Autosomal recessive polycystic kidney disease (ARPKD)
    • Chromosomal aberrations (e.g., trisomy 18)
    • Intrauterine infections (e.g., congenital TORCH infections)
    • In multiple pregnancies: twin-to-twin transfusion syndrome
  • Maternal conditions
    • Placental insufficiency
    • Late or postterm pregnancies (> 42 weeks of gestation)
    • Premature rupture of membranes
    • Preeclampsia
  • Idiopathic
• Diagnosis ^[38]
  • Small abdominal girth and uterine size for gestational age
  • Ultrasound: determine amniotic fluid and assess for fetal anomalies
  • Amniotic fluid index (AFI): a semiquantitative tool used to assess amniotic fluid volume (normal range: 8–18 cm)
    • Determined by dividing the uterus into 4 quadrants, holding the transducer perpendicular to the patient's spine, and adding up the deepest vertical pocket of fluid in each quadrant.
    • Oligohydramnios: < 5
    • In pregnancies < 24 weeks and multiple gestations, the single deepest pocket is used (normal range: 2–8 cm).
• Treatment
  • Amnioinfusion: infusion of fluid into the amniotic cavity through amniocentesis
  • Treat underlying cause: See “Preeclampsia,” “Premature rupture of membranes,” and “Placental insufficiency.”
  • Delivery is advised if the fetus is close to term.
• Complications
  • Intrauterine growth restriction (due to diminished mobility of the fetus)
  • Birth complications (e.g., umbilical cord compression)
  • Potter sequence
    • Etiology
      • Chronic placental insufficiency
      • ↓ Renal output (e.g., due to bilateral renal agenesis, ARPKD, obstruction of posterior urethral valves)
    • Pathophysiology: oligohydramnios → intrauterine compression and decreased amniotic fluid ingestions → ↓ space for fetal development → internal and external deformations
    • Clinical features
      • Pulmonary hypoplasia (cause of death due to severe neonatal respiratory insufficiency)
      • Craniofacial abnormalities (e.g., prominent epicanthal folds, flattened nose, receding chin, low set ears)
      • Wrinkling of the skin
      • Limb anomalies (e.g., bowed legs, clubbed feet)

Potter babies cannot Pee.

POTTER sequence: Pulmonary hypoplasia (lethal), Oligohydramnios (origin), Twisted facies, Twisted skin, Extremity deformities, and Renal agenesis (classic form).

Polyhydramnios ^[39]

• Definition: excessive amniotic fluid volume expected for gestational age that results in uterine distention.
• Etiology
  • Typically idiopathic (∼ 70% of cases) ^[40]
  • Fetal anomalies
    • Gastrointestinal (e.g., esophageal atresia, duodenal atresia and stenosis): reduced swallowing and absorption of amniotic fluid
    • CNS: anencephaly; (leads to impaired swallowing of amniotic fluid, leakage of cerebrospinal fluid, and increased urination due to lack of fetal ADH), meningomyelocele (due to leakage of cerebrospinal fluid) ^[41]
    • Pulmonary: cystic lung malformations
    • Multiple pregnancy: twin-to-twin transfusion syndrome
    • Fetal anemia ^[42]
    • Chromosomal aberrations
    • Intrauterine infections (e.g., congenital TORCH infections)
  • Maternal conditions
    • Diabetes mellitus
    • Rh incompatibility (e.g., hemolytic disease of the newborn)
• Diagnostics
  • Physical examination: abdominal girth and uterine size large for gestational age
  • Ultrasound
    • AFI ≥ 25
    • Assess for fetal anomalies
  • Others
    • Rh screen
    • Blood glucose
• Treatment
  • Amnioreduction: drainage of excess amniotic fluid
  • Treat the underlying cause (e.g., glycemic control in diabetic mothers, intrauterine exchange transfusion in hemolytic disease of the newborn)
• Complications
  • Fetal malposition
  • Umbilical cord prolapse
  • Premature birth
  • Premature rupture of membranes
  • Premature uterine contractions

Other complications

• Hemolytic disease of the fetus and newborn
• Intrauterine growth restriction
• Teratogenic birth defects

• One-Minute Telegram 9-2020-2/3: COVID-19: Pregnant women at increased risk for complications

Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.

1. Anthony J, Osman A, Sani M. Valvular heart disease in pregnancy. Cardiovasc J Afr. 2016; 27 (2): p.111-118. doi: 10.5830/cvja-2016-052 . | Open in Read by QxMD
2. Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016; 27 (2): p.89-94. doi: 10.5830/cvja-2016-021 . | Open in Read by QxMD
3. LoMauro A, Aliverti A. Respiratory physiology of pregnancy. Breathe. 2015; 11 (4): p.297-301. doi: 10.1183/20734735.008615 . | Open in Read by QxMD
4. Magon N, Kumar P. Hormones in pregnancy. Nigerian Medical Journal. 2012; 53 (4): p.179. doi: 10.4103/0300-1652.107549 . | Open in Read by QxMD
5. Cignini P, Cafà EV, Giorlandino C, Capriglione S, Spata A, Dugo N. Thyroid physiology and common diseases in pregnancy: review of literature.. Journal of prenatal medicine. 2012; 6 (4): p.64-71.
6. Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological Changes in Hematological Parameters During Pregnancy. Indian Journal of Hematology and Blood Transfusion. 2012; 28 (3): p.144-146. doi: 10.1007/s12288-012-0175-6 . | Open in Read by QxMD
7. Bremme KA. Haemostatic changes in pregnancy.. Best Pract Res Clin Haematol. 2003; 16 (2): p.153-168.
8. Reese JA, Peck JD, Deschamps DR, et al. Platelet Counts during Pregnancy. N Engl J Med. 2018; 379 (1): p.32-43. doi: 10.1056/nejmoa1802897 . | Open in Read by QxMD
9. Tunzy, Gray. Common Skin Conditions During Pregnancy. American Family Physician. 2007 .
10. Probable signs of pregnancy. https://brooksidepress.org/ob_newborn_care_1/?page_id=288&cn-reloaded=1. Updated: July 30, 2016. Accessed: September 2, 2020.
11. Tezuka et al.. Embryonic Heart Rates: Development in Early First Trimester and Clinical Evaluation. Gynecol Obstet Invest. 1991; 32 (4): p.210-212. doi: 10.1159/000293033 . | Open in Read by QxMD
12. Obstetric Ultrasound. http://www.ob-ultrasound.net/. . Accessed: June 6, 2019.
13. ISUOG. ISUOG Practice Guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound in Obstetrics & Gynecology. 2012; 41 (1): p.102-113. doi: 10.1002/uog.12342 . | Open in Read by QxMD
14. Hart TD, Harris MB. Preeclampsia revisited. US Pharm. 2012; 37 (9): p.48-53.
15. American College of Obstetricians and Gynecologists.. ACOG Committee Opinion No. 764.Medically indicated late-preterm and early-term deliveries.. American Journal of Obstetrics and Gynecology.. 2019 .
16. Dubil EA, Magann EF. Amniotic fluid as a vital sign for fetal wellbeing. Australasian Journal of Ultrasound in Medicine. 2013; 16 (2): p.62-70. doi: 10.1002/j.2205-0140.2013.tb00167.x . | Open in Read by QxMD
17. Mousavi AS, Hashemi N, Kashanian M, Sheikhansari N, Bordbar A, Parashi S. Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm. J Obstet Gynaecol (Lahore). 2018; 38 (5): p.611-615. doi: 10.1080/01443615.2017.1394280 . | Open in Read by QxMD
18. Salhan S. Textbook of Obstetrics. JP Medical Ltd ; 2016
19. Taskin S, Pabuccu EG, Kanmaz AG, Kahraman K, Kurtay G. Perinatal outcomes of idiopathic polyhydramnios. Interventional Medicine and Applied Science. 2013; 5 (1): p.21-25. doi: 10.1556/imas.5.2013.1.4 . | Open in Read by QxMD
20. Sahni M, Ohri A. Meningomyelocele. StatPearls. 2020 .
21. Hamza A, Herr D, Solomayer E, Meyberg-Solomayer G. Polyhydramnios: Causes, Diagnosis and Therapy. Geburtshilfe Frauenheilkd. 2013; 73 (12): p.1241-1246. doi: 10.1055/s-0033-1360163 . | Open in Read by QxMD
22. Committee on Obstetric Practice. ACOG Committee Opinion No. 650: Physical Activity and Exercise During Pregnancy and the Postpartum Period. ACOG Comm Opin. 2015 . doi: 10.1097/AOG.0000000000001214 . | Open in Read by QxMD
23. Le T, Bhushan V, Vasan N. First Aid Step 1. McGraw-Hill Medical; 20th Revised edition edition (2009) ; 2009 : p. 176
24. Le T, Bhushan V,‎ Sochat M, Chavda Y, Zureick A. First Aid for the USMLE Step 1 2018. McGraw-Hill Medical ; 2017
25. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27 (3): p.315-389. doi: 10.1089/thy.2016.0457 . | Open in Read by QxMD
26. American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2018; 42 (Supplement 1): p.S165-S172. doi: 10.2337/dc19-s014 . | Open in Read by QxMD
27. Farahi N, Zolotor A. Recommendations for preconception counseling and care.. Am Fam Physician. 2013; 88 (8): p.499-506.
28. ACOG. ACOG Committee Opinion No. 762. Obstetrics & Gynecology. 2019; 133 (1): p.e78-e89. doi: 10.1097/aog.0000000000003013 . | Open in Read by QxMD
29. Alcohol use in pregnancy. https://www.cdc.gov/ncbddd/fasd/alcohol-use.html. Updated: April 30, 2020. Accessed: August 28, 2020.
30. Dietary guidelines for Americans 2015-2020. https://health.gov/sites/default/files/2019-09/2015-2020_Dietary_Guidelines.pdf. Updated: December 1, 2015. Accessed: August 28, 2020.
31. Soneji S, Beltrán-Sánchez H. Association of Special Supplemental Nutrition Program for Women, Infants, and Children With Preterm Birth and Infant Mortality. JAMA Network Open. 2019; 2 (12): p.e1916722. doi: 10.1001/jamanetworkopen.2019.16722 . | Open in Read by QxMD
32. Bibbins-Domingo et al.. Folic Acid Supplementation for the Prevention of Neural Tube Defects. JAMA. 2017; 317 (2): p.183-189. doi: 10.1001/jama.2016.19438 . | Open in Read by QxMD
33. Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJ, Nicholson WK. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.. JAMA. 2017; 317 (2): p.190-203. doi: 10.1001/jama.2016.19193 . | Open in Read by QxMD
34. McNulty B, McNulty H, Marshall B, et al. Impact of continuing folic acid after the first trimester of pregnancy: findings of a randomized trial of Folic Acid Supplementation in the Second and Third Trimesters.. Am J Clin Nutr. 2013; 98 (1): p.92-8. doi: 10.3945/ajcn.112.057489 . | Open in Read by QxMD
35. Cantor et al.. Routine Iron Supplementation and Screening for Iron Deficiency Anemia in Pregnancy: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015; 162 (8): p.566. doi: 10.7326/m14-2932 . | Open in Read by QxMD
36. Calcium. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/. . Accessed: June 6, 2019.
37. Mahadevan S, Kumaravel V, Bharath R. Calcium and bone disorders in pregnancy. Indian J Endocrinol Metab. 2012; 16 (3): p.358–363. doi: 10.4103/2230-8210.95665 . | Open in Read by QxMD
38. Calcium and bone disorders in pregnancy..
39. Stagnaro-Green A et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011; 21 (10): p.1081-1125. doi: 10.1089/thy.2011.0087 . | Open in Read by QxMD
40. Weight gain during pregnancy. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregnancy-weight-gain.htm. Updated: January 17, 2019. Accessed: August 28, 2020.
41. Obstetrics Data Definitions. https://www.acog.org/practice-management/health-it-and-clinical-informatics/revitalize-obstetrics-data-definitions. Updated: January 1, 2014. Accessed: August 27, 2020.
42. Spong CY. Defining “Term” Pregnancy. JAMA. 2013; 309 (23): p.2445. doi: 10.1001/jama.2013.6235 . | Open in Read by QxMD
43. Ferri FF. Ferri's Clinical Advisor 2017. Elsevier ; 2016 : p. 1345-1346
44. Callahan TL, Caughey AB. Blueprints Obstetrics and Gynecology. Lippincott Williams&Wilki ; 2013
45. Medical Embryology, the Placenta: Decidual Formation.
46. Smith JA, Refuerzo JS, Ramin SM, Lockwood CJ, Barss VA. Treatment and Outcome of Nausea and Vomiting of Pregnancy. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/treatment-and-outcome-of-nausea-and-vomiting-of-pregnancy.Last updated: January 3, 2017. Accessed: June 16, 2017.
47. Ehsanipoor RM, Satin AJ, Lockwood CJ, Barss VA. Normal and Abnormal Labor Progression. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/normal-and-abnormal-labor-progression.Last updated: June 7, 2017. Accessed: June 16, 2017.
48. Refuerzo JS, Smith JA, Ramin SM, Lockwood CL, Barss VA. Clinical Features and Evaluation of Nausea and Vomiting of Pregnancy. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-features-and-evaluation-of-nausea-and-vomiting-of-pregnancy.Last updated: January 3, 2017. Accessed: July 7, 2017.
49. American College of Obstetricians and Gynecologists. Practice Bulletin No. 142: Cerclage for the Management of Cervical Insufficiency. Obstet Gynecol. 2014; 123 (2): p.372-379. doi: 10.1097/01.AOG.0000443276.68274.cc . | Open in Read by QxMD
50. Ressel GW. ACOG Releases Bulletin on Managing Cervical Insufficiency. Am Fam Physician. 2004; 69 (2): p.436-439.
51. Norwitz ER, Saade GA, Miller HS, Davidson CM. Obstetric Clinical Algorithms. Wiley-Blackwell ; 2016
52. Berghella V, Lockwood CJ, Barss VA. Cervical Insufficiency. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/cervical-insufficiency.Last updated: January 4, 2017. Accessed: July 7, 2017.
53. Tao Le, Vikas Bhushan, Deol M, Reyes G. First Aid for the USMLE Step 2 CK, Tenth Edition. McGraw-Hill Education ; 2018
54. Ciobanu et al.. Thrombocytopenia in Pregnancy.. Maedica. 2016; 11 (1): p.55-60.
55. Valenti O, Di Prima FA, Renda E, et al. Fetal cardiac function during the first trimester of pregnancy.. Journal of prenatal medicine. 2011; 5 (3): p.59-62.